Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say
10:30am, Tuesday, 10'th Feb 2026
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street est
CVS Health posts strong Q4 revenue, raises full-year guidance
10:07am, Tuesday, 10'th Feb 2026
CVS Health Corp (NYSE:CVS) on Tuesday reported stronger-than-expected fourth-quarter revenue and adjusted earnings, driven by growth across its pharmacy, health services, and insurance businesses. The
CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates
08:41am, Tuesday, 10'th Feb 2026
CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.19 per share a year ago.
The CVS Earnings Bombshell That Has Investors Scrambling Right Now
08:35am, Tuesday, 10'th Feb 2026
CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations.
First Look: Novo sues Hims, BP halts buybacks, Meta faces trial
07:39am, Tuesday, 10'th Feb 2026
Stock News Novo sues Hims over compounded weight-loss drugs: Novo Nordisk (NVO) filed suit to stop Hims and Hers Health (HIMS) from selling compounded semaglutide
CVS Profits Hit Nearly $3 Billion As Aetna's Costs Slowly Stabilize
07:00am, Tuesday, 10'th Feb 2026
CVS Health Tuesday reported $2.9 billion in fourth quarter net income as the company slowly begins to get a handle on costs that have hit its Aetna health insurance business hard.
CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist.
06:53am, Tuesday, 10'th Feb 2026
CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.
CVS Health's turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses
06:42am, Tuesday, 10'th Feb 2026
The healthcare giant saw its revenue jump 8% in the fourth quarter
CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector
06:37am, Tuesday, 10'th Feb 2026
CVS Health reported earnings that beat analysts' expectations and kept its 2026 profit guidance unchanged, results that may soothe investors spooked by continued turmoil in the health-insurance sector
CVS Health beats quarterly profit expectations on pharmacy performance
06:34am, Tuesday, 10'th Feb 2026
CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription volume at its retail pharmacie
CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect
06:30am, Tuesday, 10'th Feb 2026
CVS Health reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that previously impressed investors. The results signal steady progress in the healt
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
06:30am, Tuesday, 10'th Feb 2026
Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior year GAAP diluted EPS of $2.30 and Adjusted EPS of $1.09 Full-Year Highlights Total revenues increased t
Versor Investments LP Sells 17,798 Shares of CVS Health Corporation $CVS
05:24am, Tuesday, 10'th Feb 2026
Versor Investments LP lessened its stake in CVS Health Corporation (NYSE: CVS) by 32.7% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (S
CVS Health posts strong Q4 revenue, raises full-year guidance
05:04am, Tuesday, 10'th Feb 2026
CVS Health Corp (NYSE:CVS) on Tuesday reported stronger-than-expected fourth-quarter revenue and adjusted earnings, driven by growth across its pharmacy,...
CVS Health Corporation $CVS Shares Sold by Candriam S.C.A.
04:42am, Tuesday, 10'th Feb 2026
Candriam S.C.A. reduced its stake in CVS Health Corporation (NYSE: CVS) by 16.4% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 190,958 s
